TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
PFE

Pfizer Inc

Healthcare · Drug Manufacturers - General

27.70$ +0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Pfizer Inc (PFE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 11,705 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow PFE
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2,067 1,629 2,929 3,056 6,195 9,263 10,183 11,739 16,340 14,733 17,594 13,353 18,238 16,587 11,454 20,240 17,054 17,765 16,883 14,512 15,901 16,470 15,827 12,588 14,403 32,580 29,267 8,700 12,744 11,705
430 502 489 542 968 1,068 1,036 4,078 5,093 5,576 5,293 5,200 5,090 4,757 8,487 9,026 7,611 6,410 5,537 5,157 5,757 6,269 6,384 6,010 4,777 5,191 5,064 6,290 7,013 6,592
290 8.0 36 2,700 -10,476 -158 -20 349 405 419 481 523 586 669 691 840 949 718 756 1,182 872 525 877 799
1,315 298 1,736 805 172 2,909 647 -9,165 5,969 19 -4,807 -7,153 757 1,803 1,101 -1,792 -222 2,863 2,886 -7,307 -2,742
-381 -1,110 224 -1,261 1,803 446 3.0 -693 -862 -586 3,016 -800 4,859 12,517 -10,426 2,729 -1,942 -3,392 1,423 564 85 1,296 -926 -4,031 -275 12,804 -4,456 -2,172 -3,066 -5,354
774 943 1,198 1,561 2,191 2,203 1,758 2,641 2,601 2,106 2,050 1,880 1,701 1,205 1,513 1,660 1,327 1,465 1,583 1,496 1,999 2,217 2,196 2,594 2,791 2,711 3,236 3,907 2,909 2,629
-937 -1,022 -335 -2,768 -3,753 -7,225 -4,338 4,838 -9,422 -5,072 5,101 795 -12,835 -31,272 -492 2,200 6,154 -10,625 -5,654 -2,980 -7,811 -4,741 4,525 -3,945 -4,271 -22,546 -15,783 -32,278 2,652 -1,351
771 881 976 1,148 2,197 2,715 3,168 4,353 5,082 5,555 6,919 7,975 8,541 5,548 6,088 6,234 6,534 6,580 6,609 6,940 7,317 7,659 7,978 8,043 8,440 8,729 8,983 9,247 9,512 9,771
-27 -586 -2,177 -2,542 -1,005 -3,665 -4,996 -13,037 -6,659 -3,797 -6,979 -9,994 -500 0.0 -1,000 -9,000 -8,228 -16,290 -5,000 -6,160 -5,000 -5,000 -12,198 -8,865 425 0.0 -2,000 0.0 0.0
23,056 -6.0 -1,715 -1,722 6,036 549 1,306 2,573 -1,005 -935 8,764 -12,755 -1,103 -3,516 35,945 -7,159 -74
-382 -848 -1,920 -1,127 -3,705 -2,096 -4,999 -16,909 -6,629 -9,222 -23,100 -12,610 -6,560 14,481 -11,174 -20,607 -15,999 -14,975 -9,986 -10,233 -8,921 -13,035 -20,441 -8,485 -9,649 -9,816 -14,834 26,066 -17,140 -10,304
747 -273 675 -813 -1,259 -63 842 -358 288 439 -420 1,579 -1,284 -144 -243 1,804 7,207 -7,898 1,160 298 -1,046 -1,253 -206 125 475 158 -1,515 2,449 -1,810 99
1,293 686 1,731 1,495 4,004 7,060 8,425 9,098 13,739 12,627 15,544 11,473 16,537 15,382 9,941 18,580 15,727 16,300 15,300 13,016 13,902 14,253 13,631 9,994 11,612 29,869 26,031 4,793 9,835 9,076

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?